Dr. Sarah J. Sinclair
Claim this profileLafayette Family Cancer Center-EMMC
Expert in Cancer
Expert in Breast Cancer
77 reported clinical trials
153 drugs studied
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
KRAS positive
2Breast Cancer
Global LeaderHER2 positive
ER positive
Stage IV
Affiliated Hospitals
Clinical Trials Sarah J. Sinclair is currently running
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. Chemotherapy drugs, such as lomustine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy photons to kill tumor cells and shrink tumors. Adding lomustine to usual treatment of temozolomide and radiation therapy may help shrink and stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
High-Dose vs Low-Dose Cisplatin with Radiation
for Head and Neck Cancer
This phase II/III trial compares the effect of the combination of high-dose cisplatin every three weeks and radiation therapy versus low-dose cisplatin weekly and radiation therapy for the treatment of patients with locoregionally advanced head and neck cancer. Chemotherapy drugs, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. This study is being done to find out if low-dose cisplatin given weekly together with radiation therapy is the same or better than high-dose cisplatin given every 3 weeks together with radiation therapy in treating patients with head and neck cancer.
Recruiting1 award Phase 2 & 335 criteria
More about Sarah J. Sinclair
Clinical Trial Related4 years of experience running clinical trials · Led 77 trials as a Principal Investigator · 40 Active Clinical TrialsTreatments Sarah J. Sinclair has experience with
- Paclitaxel
- Pembrolizumab
- Carboplatin
- Fluorouracil
- Radiation Therapy
- Nivolumab
Breakdown of trials Sarah J. Sinclair has run
Cancer
Breast Cancer
Lung Cancer
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sarah J. Sinclair specialize in?
Sarah J. Sinclair focuses on Cancer and Breast Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Sarah J. Sinclair currently recruiting for clinical trials?
Yes, Sarah J. Sinclair is currently recruiting for 37 clinical trials in Brewer Maine. If you're interested in participating, you should apply.
Are there any treatments that Sarah J. Sinclair has studied deeply?
Yes, Sarah J. Sinclair has studied treatments such as Paclitaxel, Pembrolizumab, Carboplatin.
What is the best way to schedule an appointment with Sarah J. Sinclair?
Apply for one of the trials that Sarah J. Sinclair is conducting.
What is the office address of Sarah J. Sinclair?
The office of Sarah J. Sinclair is located at: Lafayette Family Cancer Center-EMMC, Brewer, Maine 04412 United States. This is the address for their practice at the Lafayette Family Cancer Center-EMMC.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.